These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 14581493)

  • 1. Molecular biology and pharmacology of PDE-5-inhibitor therapy for erectile dysfunction.
    Corbin JD; Francis SH
    J Androl; 2003; 24(6 Suppl):S38-41. PubMed ID: 14581493
    [No Abstract]   [Full Text] [Related]  

  • 2. An update on the PDE-5 inhibitors (PDE-5i).
    McCullough AR
    J Androl; 2003; 24(6 Suppl):S52-8. PubMed ID: 14581496
    [No Abstract]   [Full Text] [Related]  

  • 3. New phosphodiesterase type 5 inhibitors in the management of erectile dysfunction.
    Mason RG
    J R Soc Promot Health; 2003 Jun; 123(2):79-80. PubMed ID: 12852189
    [No Abstract]   [Full Text] [Related]  

  • 4. [Levitra (vardenafil)--a new PDE 5 inhibitor for the treatment of erectile dysfunction].
    Katsarov M
    Akush Ginekol (Sofiia); 2004; 43 Suppl 1():31-2. PubMed ID: 15323315
    [No Abstract]   [Full Text] [Related]  

  • 5. [New PDE-5 inhibitor for treatment of impotence. 9 out of 10 have erections again].
    MMW Fortschr Med; 2003 Jun; 145(26):59. PubMed ID: 12916343
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Montorsi F; Briganti A; Salonia A; Montorsi P; Rigatti P
    Curr Opin Urol; 2004 Nov; 14(6):357-9. PubMed ID: 15626879
    [No Abstract]   [Full Text] [Related]  

  • 7. Erectile dysfunction and cardiovascular considerations: managing patients effectively with phosphodiesterase type 5 inhibitors.
    Hutter AM
    Clin Cardiol; 2004 Apr; 27(4 Suppl 1):I1-2. PubMed ID: 15115188
    [No Abstract]   [Full Text] [Related]  

  • 8. Phosphodiesterase type 5 (PDE5) inhibitors.
    Haning H; Niewöhner U; Bischoff E
    Prog Med Chem; 2003; 41():249-306. PubMed ID: 12774696
    [No Abstract]   [Full Text] [Related]  

  • 9. [7 years PDE-5 inhibitor for therapy of erection disorders].
    Krankenpfl J; 2005; 43(7-10):267. PubMed ID: 16518894
    [No Abstract]   [Full Text] [Related]  

  • 10. [PDE-5 inhibitor with improved pharmacokinetics. Far-reaching return to normality].
    MMW Fortschr Med; 2003 Mar; 145(11):56-7. PubMed ID: 12688198
    [No Abstract]   [Full Text] [Related]  

  • 11. [Some aspects of erectile dysfunction pathogenesis and treatment in patients with obesity].
    Ametov AS; Teodorovich OV; Kondrat'eva LV; Popova AIu
    Ter Arkh; 2006; 78(2):92-4. PubMed ID: 16613108
    [No Abstract]   [Full Text] [Related]  

  • 12. Vasoactive pharmacotherapy to cure erectile dysfunction: fact or fiction?
    Burnett AL
    Urology; 2005 Feb; 65(2):224-30. PubMed ID: 15708027
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction.
    Briganti A; Salonia A; Deho' F; Zanni G; Barbieri L; Rigatti P; Montorsi F
    World J Urol; 2005 Dec; 23(6):374-84. PubMed ID: 16273417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tadalafil and vardenafil.
    Neumeyer K; Kirkpatrick P
    Nat Rev Drug Discov; 2004 Apr; 3(4):295-6. PubMed ID: 15124623
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison of efficacy and safety of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction].
    Chen Q; Wang N; Yao F; Lu X
    Zhonghua Nan Ke Xue; 2004 Apr; 10(4):302-4. PubMed ID: 15148932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Erectile dysfunction: an update on new therapeutic options].
    Roumeguère T
    Acta Urol Belg; 2000; 68(2):41-2. PubMed ID: 11098588
    [No Abstract]   [Full Text] [Related]  

  • 17. [Phosphodiesterase-5 inhibitor with broad temporal effectiveness window].
    MMW Fortschr Med; 2004 Apr; 146(16):62. PubMed ID: 15222506
    [No Abstract]   [Full Text] [Related]  

  • 18. Phosphodiesterase-5 inhibition: the molecular biology of erectile function and dysfunction.
    Francis SH; Corbin JD
    Urol Clin North Am; 2005 Nov; 32(4):419-29, vi. PubMed ID: 16291034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vardenafil--PDE5 inhibitor number 3.
    Jackson G
    Int J Clin Pract; 2004 Mar; 58(3):229. PubMed ID: 15117087
    [No Abstract]   [Full Text] [Related]  

  • 20. Phosphodiesterase inhibitors for the treatment of erectile dysfunction.
    Küthe A; Montorsi F; Andersson KE; Stief CG
    Curr Opin Investig Drugs; 2002 Oct; 3(10):1489-95. PubMed ID: 12431025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.